Hvas CL - Search Results

1

Randomised clinical trial: high-dose oral thiamine versus placebo for chronic fatigue in patients with quiescent inflammatory bowel disease.

Bager P, Hvas CL, Rud CL, Dahlerup JF. Bager P, et al. Among authors: hvas cl. Aliment Pharmacol Ther. 2021 Jan;53(1):79-86. doi: 10.1111/apt.16166. Epub 2020 Nov 18. Aliment Pharmacol Ther. 2021. PMID: 33210299 Clinical Trial.

2

FoxP3(+)CD4(+)CD25(+) T cells with regulatory properties can be cultured from colonic mucosa of patients with Crohn's disease.

Kelsen J, Agnholt J, Hoffmann HJ, Rømer JL, Hvas CL, Dahlerup JF. Kelsen J, et al. Among authors: hvas cl. Clin Exp Immunol. 2005 Sep;141(3):549-57. doi: 10.1111/j.1365-2249.2005.02876.x. Clin Exp Immunol. 2005. PMID: 16045746 Free PMC article.

3

[CD4 + CD25 + regulatory T cells and their importance to human illnesses].

Kelsen J, Hvas CL, Agnholt J, Dahlerup JF. Kelsen J, et al. Among authors: hvas cl. Ugeskr Laeger. 2006 Jan 3;168(1):32-7. Ugeskr Laeger. 2006. PMID: 16393560 Review. Danish.

4

Osteopontin, a protein with cytokine-like properties, is associated with inflammation in Crohn's disease.

Agnholt J, Kelsen J, Schack L, Hvas CL, Dahlerup JF, Sørensen ES. Agnholt J, et al. Among authors: hvas cl. Scand J Immunol. 2007 May;65(5):453-60. doi: 10.1111/j.1365-3083.2007.01908.x. Scand J Immunol. 2007. PMID: 17444956 Free article.

5

Crohn's disease intestinal CD4+ T cells have impaired interleukin-10 production which is not restored by probiotic bacteria.

Hvas CL, Kelsen J, Agnholt J, Höllsberg P, Tvede M, Møller JK, Dahlerup JF. Hvas CL, et al. Scand J Gastroenterol. 2007 May;42(5):592-601. doi: 10.1080/00365520601013754. Scand J Gastroenterol. 2007. PMID: 17454880

6

1,25-dihydroxyvitamin D3 and dexamethasone increase interleukin-10 production in CD4+ T cells from patients with Crohn's disease.

Bartels LE, Jørgensen SP, Agnholt J, Kelsen J, Hvas CL, Dahlerup JF. Bartels LE, et al. Among authors: hvas cl. Int Immunopharmacol. 2007 Dec 15;7(13):1755-64. doi: 10.1016/j.intimp.2007.09.016. Epub 2007 Oct 5. Int Immunopharmacol. 2007. PMID: 17996686

7

Toll-like receptor-induced granulocyte-macrophage colony-stimulating factor secretion is impaired in Crohn's disease by nucleotide oligomerization domain 2-dependent and -independent pathways.

Brosbøl-Ravnborg A, Hvas CL, Agnholt J, Dahlerup JF, Vind I, Till A, Rosenstiel P, Höllsberg P. Brosbøl-Ravnborg A, et al. Among authors: hvas cl. Clin Exp Immunol. 2009 Mar;155(3):487-95. doi: 10.1111/j.1365-2249.2008.03850.x. Epub 2008 Dec 15. Clin Exp Immunol. 2009. PMID: 19094116 Free PMC article.

8

Ethylene-Diamine-Tetra-Acetate (EDTA) mimics the effect of regulatory T cells in suppression assays: a potential pitfall when using AutoMACS-separated cells.

Dige A, Hvas CL, Kelsen J, Deleuran B, Dahlerup JF, Agnholt J. Dige A, et al. Among authors: hvas cl. J Immunol Methods. 2010 Feb 28;353(1-2):141-4. doi: 10.1016/j.jim.2009.11.019. Epub 2009 Dec 1. J Immunol Methods. 2010. PMID: 19958773

9

Discrete changes in circulating regulatory T cells during infliximab treatment of Crohn's disease.

Hvas CL, Kelsen J, Agnholt J, Dige A, Christensen LA, Dahlerup JF. Hvas CL, et al. Autoimmunity. 2010 Jun;43(4):325-33. doi: 10.3109/08916930903509064. Autoimmunity. 2010. PMID: 20298123

10

Human dendritic cell antigen presentation and chemotaxis are inhibited by intrinsic 25-hydroxy vitamin D activation.

Bartels LE, Hvas CL, Agnholt J, Dahlerup JF, Agger R. Bartels LE, et al. Among authors: hvas cl. Int Immunopharmacol. 2010 Aug;10(8):922-8. doi: 10.1016/j.intimp.2010.05.003. Epub 2010 May 17. Int Immunopharmacol. 2010. PMID: 20483384

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results